Peter Heerma

Insider Reports History

Entity
Individual
Location
C/O Travere Therapeutics, Inc., 3611 Valley Centre Drive, Suite 300, San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Heerma:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Common Stock 108K $1.24M $11.52 Sep 9, 2024 Direct
Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Employee stock option (right to buy) 65K Jan 31, 2024 Direct

Insider Reports Filed by Peter Heerma

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVTX Travere Therapeutics, Inc. Sep 5, 2024 2 -$25.2K 4 Sep 9, 2024 CHIEF COMMERCIAL OFFICER
TVTX Travere Therapeutics, Inc. Jan 31, 2024 3 -$35.8K 4 Feb 2, 2024 CHIEF COMMERCIAL OFFICER
TVTX Travere Therapeutics, Inc. Jan 23, 2024 1 -$14.1K 4 Jan 25, 2024 CHIEF COMMERCIAL OFFICER
TVTX Travere Therapeutics, Inc. Oct 3, 2023 1 -$25.5K 4 Oct 4, 2023 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2023 4 -$38.7K 4 Feb 2, 2023 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2023 1 -$34K 4 Jan 26, 2023 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Oct 4, 2022 1 -$78.1K 4 Oct 6, 2022 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2022 5 -$30.8K 4 Feb 2, 2022 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2022 1 -$46.8K 4 Jan 26, 2022 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Oct 4, 2021 1 -$75.7K 4 Oct 5, 2021 Chief Commercial Officer
TVTX Travere Therapeutics, Inc. Aug 13, 2021 2 -$24.1K 4 Aug 17, 2021 Chief Commercial Officer